Baxter
BAX
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 24 days ago • BAX
Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • about a month ago • BAX
Madison Small Cap Fund Q1 2026 Portfolio Activity
Seeking Alpha • about a month ago • BAX
Baxter International Inc. (BAX) Q1 2026 Earnings Call Transcript
Zacks Investment Research • about a month ago • BAX
BAX Stock Gains on Q1 Earnings & Sales Beat, Margins Contract
Zacks Investment Research • about a month ago • BAX
Baxter (BAX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.